BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Cetero Research Grows Senior Management Team


12/21/2011 9:50:09 AM

CARY, N.C., Dec. 20, 2011 /PRNewswire/ -- Cetero Research, the leading early-stage contract research organization, today announced two new appointments to its senior management team. Michael C. Fillios was named Chief Administrative Officer, with leadership responsibility and oversight of Human Resources, Information Technology, Project Management, Marketing and Client Services. David Coggin was named Vice President, Biometrics. He will oversee the operational management of PK/PD, Data Management, Biostatistics and Medical Writing Services. Both positions report directly to Chief Executive Officer Troy W. McCall, Ph.D.

Mr. Fillios is a 21-year veteran of industries spanning pharmaceutical manufacturing, industrial engineering and management consulting. He was most recently responsible for strategic business relationship management and process, as well as enterprise technology integration and all global business functions at ITT Corporation, a global high-tech engineering and manufacturing company.

Mr. Coggin has nearly 30 years of experience in the pharmaceutical and clinical research industries. He most recently held the role of Global Head, Early Clinical Services, Clinical Data Management, within the Clinical Data, Analysis and Reporting Organization at Covance. He has held leadership positions at Covance for the past 17 years, where he was responsible for the overall performance of biostatistics, data management, medical writing and programming services.

"Michael brings a diverse background in organizational transformation, strategic management, and business process optimization across multiple industries," said Dr. McCall. "Furthermore, David's extensive knowledge of clinical development and scientific expertise will serve Cetero well as we continue to explore and offer streamlined development approaches. Both of these accomplished leaders will help us realign infrastructure and integrate service offerings to meet the evolving needs of our customers."

Mr. Fillios has a Bachelor of Business Administration degree from The Hagen School of Business at Iona College.

Mr. Coggin earned his Bachelor of Science degree in entomology from the University of Delaware. He holds a Master of Business Administration degree from Hood College, a Master of Computer Science from the Johns Hopkins University and a Master in Entomology with emphasis in biostatistics from the University of Maryland.

About Cetero Research
Cetero Research, the leading early-stage contract research organization, has conducted more than 20,000 clinical pharmacology studies - more than any other CRO. With facilities across North America, Cetero offers flexible, high-quality clinical development services in a range of therapeutic areas, including asthma and allergy, dermatology and diabetes, as well as bioanalytical services to support preclinical, clinical, drug and biomarker analysis for small and large molecules. It uses innovative approaches, such as the Accelerated Proof-of-Concept study design to provide key decision-making data earlier in the development process. For more information, visit Cetero.com or call 877.7CETERO.

SOURCE Cetero Research



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES